NCF1 (Ab-345) Antibody

What is NCF1 and what significance does phosphorylation at Ser345 have?

NCF1 (Neutrophil Cytosol Factor 1), also known as p47 phox, is a critical component of the NADPH oxidase complex involved in respiratory burst in phagocytes. The phosphorylation at Ser345 represents a key regulatory event in NCF1 activation. The NCF1 (Ab-345) antibody specifically detects endogenous levels of p47 phox only when phosphorylated at this serine residue (Ser345), making it valuable for studying the activation state of the NADPH oxidase complex . This phosphorylation site is located within amino acids 311-360 of the human NCF1 protein and plays a crucial role in neutrophil function and oxidative burst regulation.

What are the technical specifications of the NCF1 (Ab-345) Antibody?

The NCF1 (Ab-345) Antibody is a polyclonal antibody produced in rabbits that specifically targets the phosphorylated Ser345 site of human NCF1 protein. It is available as an unconjugated antibody with purity exceeding 95% . The antibody has been validated for human samples and can be used in multiple applications including Western Blotting (WB), Enzyme-Linked Immunosorbent Assay (ELISA), and Immunohistochemistry (IHC) . It is classified as an IgG isotype antibody and demonstrates high specificity for the phosphorylated form of the protein, with minimal cross-reactivity to the non-phosphorylated form.

How is the NCF1 (Ab-345) Antibody produced and purified?

The production process involves immunizing rabbits with a synthetic phosphopeptide derived from the region surrounding the Ser345 phosphorylation site of human p47 phox (with sequence P-Q-S(p)-P-G) . The antibody is then purified through a sophisticated two-step affinity chromatography process. First, phosphopeptide-specific antibodies are isolated using epitope-specific phosphopeptide chromatography. Subsequently, the preparation undergoes a negative selection step using non-phosphorylated peptide chromatography to remove antibodies that might recognize the non-phosphorylated form of the protein . This rigorous purification strategy ensures high specificity for the phosphorylated Ser345 epitope.

What are the optimal conditions for using NCF1 (Ab-345) Antibody in Western blotting experiments?

For optimal Western blotting results with the NCF1 (Ab-345) Antibody, researchers should implement the following methodological approach:

• Sample preparation: Lyse cells in a buffer containing phosphatase inhibitors to preserve the phosphorylation state of NCF1

• Protein separation: Use 8-12% SDS-PAGE gels for effective resolution of the ~47 kDa NCF1 protein

• Transfer: Employ PVDF membranes for optimal protein binding and signal detection

• Blocking: Block with 5% BSA in TBST rather than milk to prevent phospho-epitope masking

• Primary antibody incubation: Dilute the antibody 1:500-1:1000 in blocking solution and incubate overnight at 4°C

• Detection: Use an appropriate HRP-conjugated anti-rabbit secondary antibody and enhanced chemiluminescence detection system

Researchers should include positive controls (stimulated neutrophils or cells) and negative controls (phosphatase-treated samples) to validate specificity for the phosphorylated form of NCF1 .

How can researchers verify the specificity of NCF1 (Ab-345) Antibody in their experimental system?

Verifying antibody specificity requires a multi-faceted approach:

• Phosphatase treatment: Treating a portion of positive control samples with lambda phosphatase should abolish or significantly reduce signal if the antibody is truly phospho-specific

• Competing peptide analysis: Pre-incubating the antibody with excess phosphorylated peptide (P-Q-S(p)-P-G) should block specific binding and reduce signal

• Stimulation experiments: Treating cells with stimuli known to induce NCF1 phosphorylation should increase signal compared to unstimulated controls

• Validation across multiple techniques: Comparing results from different applications (WB, ELISA, IHC) can provide confidence in antibody specificity

• Comparison with other antibodies: Using a pan-NCF1 antibody in parallel helps confirm that the protein is present even when phosphorylation signal is absent

What controls are essential when performing immunohistochemistry with the NCF1 (Ab-345) Antibody?

For robust immunohistochemistry experiments using the NCF1 (Ab-345) Antibody, the following controls are essential:

• Positive tissue control: Include tissues known to contain activated neutrophils or cells expressing phosphorylated NCF1

• Negative tissue control: Include tissues known not to express NCF1 or where phosphorylation is not expected

• Antibody controls:

  • Primary antibody omission control

  • Isotype control (rabbit IgG at equivalent concentration)

  • Secondary antibody-only control

• Antigen pre-absorption control: Pre-incubate antibody with phospho-peptide to demonstrate binding specificity

• Phosphatase-treated serial sections: Compare adjacent sections with and without phosphatase treatment

These controls help distinguish specific staining from background or non-specific antibody binding .

How can the NCF1 (Ab-345) Antibody be utilized to study NADPH oxidase activity in inflammatory conditions?

The NCF1 (Ab-345) Antibody provides a valuable tool for investigating NADPH oxidase activation in inflammatory diseases through several methodological approaches:

• Temporal phosphorylation analysis: Track the kinetics of Ser345 phosphorylation in response to inflammatory stimuli through time-course experiments

• Pharmacological intervention studies: Assess how various inhibitors or therapeutic agents affect NCF1 phosphorylation status

• Tissue analysis in disease models: Compare phospho-NCF1 levels in healthy versus inflamed tissues to correlate with disease severity

• Co-localization studies: Combine with markers of neutrophil activation to map the spatial distribution of activated cells in tissue sections

• Signaling pathway dissection: Identify upstream kinases responsible for Ser345 phosphorylation under different inflammatory conditions

This methodological approach enables researchers to understand how NADPH oxidase activation contributes to pathological oxidative stress in various inflammatory conditions .

What insights can be gained by comparing phosphorylation at Ser345 with other phosphorylation sites on NCF1?

A comprehensive understanding of NCF1 regulation requires examining multiple phosphorylation sites simultaneously:

By analyzing these sites in parallel, researchers can:

• Map sequential phosphorylation events during activation

• Identify pathway-specific regulatory mechanisms

• Develop more targeted interventions for modulating NADPH oxidase activity

• Understand how different inflammatory stimuli may preferentially activate distinct phosphorylation patterns

How can the NCF1 (Ab-345) Antibody contribute to understanding autoimmune pathologies?

NCF1 phosphorylation status can provide insights into autoimmune disease mechanisms through several research approaches:

• Neutrophil functional studies: Assess how altered NCF1 phosphorylation correlates with neutrophil dysfunction in autoimmune conditions

• Comparative tissue analysis: Examine phospho-NCF1 patterns in tissues from autoimmune disease models compared to controls

• Therapeutic response monitoring: Track changes in NCF1 phosphorylation during treatment with immunomodulatory drugs

• Biomarker development: Evaluate whether phospho-NCF1 levels in neutrophils could serve as biomarkers for disease activity

This approach is particularly relevant when studying conditions involving dysfunctional neutrophil responses, as aberrant NCF1 phosphorylation may contribute to immunopathology . Additionally, understanding phosphorylation-dependent epitope exposure could provide insights into autoantibody generation in certain autoimmune conditions, similar to mechanisms observed in other autoimmune kidney diseases where proteolysis exposes normally hidden epitopes .

What are common challenges when using NCF1 (Ab-345) Antibody and how can they be addressed?

Several technical challenges may arise when working with phospho-specific antibodies like NCF1 (Ab-345):

• Phosphorylation loss during sample preparation:

  • Solution: Add phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate) to all buffers

  • Process samples rapidly at 4°C

  • Use SDS sample buffer with phosphatase inhibitors for immediate protein denaturation

• High background in immunohistochemistry:

  • Solution: Optimize blocking (try 2-5% BSA or normal serum)

  • Increase washing steps (4-5 washes of 5 minutes each)

  • Further dilute primary antibody

  • Consider using biotin-free detection systems

• Weak or inconsistent signal:

  • Solution: Confirm phosphorylation status with stimulation controls

  • Optimize antibody concentration through titration

  • Extend incubation time or use signal amplification methods

  • Ensure samples were collected at appropriate time points when phosphorylation occurs

How should researchers analyze and quantify data generated using the NCF1 (Ab-345) Antibody?

Rigorous data analysis for experiments using the NCF1 (Ab-345) Antibody should follow these methodological guidelines:

• Western blot quantification:

  • Use densitometry software (e.g., ImageJ) with appropriate background subtraction

  • Normalize phospho-NCF1 signal to total NCF1 or loading control

  • Present data as fold-change relative to control conditions

  • Analyze at least three biological replicates

• Immunohistochemistry quantification:

  • Use digital image analysis for objective quantification

  • Establish clear positive staining thresholds

  • Quantify percentage of positive cells or staining intensity

  • Analyze multiple fields from each sample

• Statistical analysis:

  • Apply appropriate statistical tests based on data distribution

  • Use paired tests when comparing treated and untreated samples

  • For multiple comparisons, use ANOVA with post-hoc tests

  • Report exact p-values and confidence intervals

How does the NCF1 (Ab-345) Antibody compare with other antibodies in the NCF1 research toolkit?

The NCF1 antibody landscape includes various tools that complement the phospho-Ser345 antibody:

Researchers should select antibodies based on their specific experimental questions and required applications. Using complementary antibodies targeting different epitopes can provide more comprehensive insights into NCF1 regulation and function .

What emerging research areas could benefit from employing the NCF1 (Ab-345) Antibody?

Several cutting-edge research fields could benefit from incorporating NCF1 (Ab-345) Antibody in their methodological approaches:

• Neutrophil extracellular trap (NET) formation studies:

  • Investigate the relationship between NCF1 phosphorylation and NET formation kinetics

  • Examine how different stimuli affect the phosphorylation-dependent regulation of NET release

• COVID-19 and viral pathogenesis research:

  • Study how SARS-CoV-2 infection affects neutrophil activation and NCF1 phosphorylation

  • Investigate whether excessive NCF1 phosphorylation contributes to hyperinflammation in severe COVID-19

• Precision medicine for autoimmune diseases:

  • Develop phospho-NCF1 profiling as potential biomarkers for stratifying patients

  • Target specific kinase pathways leading to abnormal NCF1 phosphorylation

• Cancer immunology:

  • Examine how tumor microenvironments affect neutrophil NCF1 phosphorylation

  • Investigate whether modulating NCF1 phosphorylation can enhance anti-tumor immunity

How can advanced microscopy techniques enhance research using the NCF1 (Ab-345) Antibody?

Integrating cutting-edge microscopy with the NCF1 (Ab-345) Antibody can provide novel insights through the following methodological approaches:

• Live cell imaging:

  • Use membrane-permeable phospho-specific probes to track NCF1 phosphorylation dynamics in real-time

  • Correlate phosphorylation events with cellular activities like migration and phagocytosis

• Super-resolution microscopy:

  • Visualize nanoscale distribution of phosphorylated NCF1 during NADPH oxidase complex assembly

  • Resolve spatial relationships between phosphorylated NCF1 and other oxidase components

• Multi-parameter imaging:

  • Combine phospho-NCF1 detection with oxidative stress indicators and functional markers

  • Develop multiplexed imaging panels to comprehensively profile neutrophil activation states

• Intravital microscopy:

  • Monitor phospho-NCF1 positive neutrophils in live animal models of inflammation

  • Track the temporal and spatial dynamics of neutrophil activation in various tissue microenvironments